16-2-2-1　ⓔ文献

  1. 清野　裕，南條輝志男，他：糖尿病の分類と診断基準に関する委員会報告 (国際標準化対応版)．糖尿病，2012; 55: 485–504.

  2. 平松祐司，羽田勝計，他：日本糖尿病・妊娠学会と日本糖尿病学会との合同委員会　妊娠中の糖代謝異常と診断基準の統一化について．糖尿病，2015; 58: 801–803.

  3. Imagawa A, Hanafusa T, et al: A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes–related antibodies. Osaka IDDM Study Group. N Engl J Med, 2000; 342: 301–307.

  4. Yasuda K, Miyake K, et al: Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus. Nat Genet, 2008; 40: 1092–1097.

  5. Yamauchi T, Hara K, et al: A genome–wide association study in the Japanese population identifies susceptibility loci for type 2 diabetes at UBE2E2 and C2CD4A–C2CD4B. Nat Genet, 2010; 42: 864–868.

  6. Suzuki K, Akiyama M, et al: Identification of 28 new susceptibility loci for type 2 diabetes in the Japanese population. Nat Genet, 2019; 51: 379–386.

  7. Kadowaki T, Yamauchi T, et al: Adiponectin and adiponectin receptors in insulin resistance, diabetes and metabolic syndrome. J Clin Invest, 2006; 116: 1784–1792.

  8. Fajans SS: Scope and heterogeneous nature of MODY. Diabetes Care, 1990; 13: 49–64.

  9. Kadowaki T, Kadowaki H, et al: A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA. N Engl J Med, 1994; 330: 962–968.

  10. Gloyn AL, Pearson ER, et al: Activating mutations in the gene encoding the ATP–sensitive potassium–channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med, 2004; 350: 1838–1849.

  11. Babenko AP, Polak M, et al: Activating mutations in the ABCC8 gene in neonatal diabetes mellitus. N Engl J Med, 2006; 355: 456–466.

  12. Kasuga M, Kadowaki T: Insulin receptor disorders in Japan. Diabetes Res Clin Pract, 1994; 24: S145–151.